Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Expanded Program on Immunization (EPI) has led to large reductions in morbidity and mortality among children in low-income countries. However, the basic EPI schedule may no longer be optimal because of changes in vaccines, programs, and epidemiologic circumstances. In addition, evidence has accumulated that some EPI vaccines may have nonspecific effects that increase or decrease mortality from subsequent infections with other unrelated organisms. There is therefore a need for randomized trials to evaluate the effects of alternative EPI schedules on all-cause mortality, as well as vaccine efficacy against the target diseases. We have reviewed the available literature on the nonspecific effects of vaccines on mortality, and compiled a list of potential trials that might address this issue. We have then ranked the trials based on the potential importance of the results and the ethical and practical considerations. Trials of early BCG vaccination in low-birth-weight babies, early measles vaccination, and altered timing of DTP vaccination all have a high priority.

Original publication

DOI

10.1097/INF.0b013e3181c91361

Type

Journal article

Journal

Pediatr Infect Dis J

Publication Date

05/2010

Volume

29

Pages

457 - 461

Keywords

BCG Vaccine, Child, Child, Preschool, Communicable Disease Control, Communicable Diseases, Developing Countries, Diphtheria-Tetanus-Pertussis Vaccine, Humans, Infant, Infant, Newborn, Measles Vaccine, Randomized Controlled Trials as Topic, Vaccines